Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oregon Technology Today.
May 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | |||
5 | 6 | 7 | 8 | 9 | 10 | 11 |
12 | 13 | 14 | 15 | 16 | 17 | 18 |
19 | 20 | 21 | 22 | 23 | 24 | 25 |
26 | 27 | 28 | 29 | 30 | 31 |
June 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | ||||||
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 | 29 |
30 |
July 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
7 | 8 | 9 | 10 | 11 | 12 | 13 |
14 | 15 | 16 | 17 | 18 | 19 | 20 |
21 | 22 | 23 | 24 | 25 | 26 | 27 |
28 | 29 | 30 | 31 |
Press releases published on May 28, 2025

Link Oregon Names Seasoned Researcher and Non-Profit Leader Jackie Wirz as Executive Director
Wirz will lead efforts to expand reach of Link Oregon’s state-of-the-art fiber network and unlock benefits of the data economy for all Oregonians PORTLAND, OR, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- Link Oregon, the statewide non-profit …

Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with Schizophrenia at American Society of Clinical Psychopharmacology 2025
Tokyo, Japan and Cambridge, UK, 29 May 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) notes that Neurocrine Biosciences, Inc. announced that it had presented new positive data from the Phase 2 study of NBI-1117568 in adults with …

FOBI AI Inc. Announces Sale of German Subsidiary
Vancouver, BC, May 28, 2025 (GLOBE NEWSWIRE) -- FOBI AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (“Fobi” or the “Company”) announces that it has entered into a share purchase agreement dated May 28, 2025 (the “Agreement”), with an arm’s length third party purchaser …

Rakovina Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations
VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”) announces that in accordance with the terms of an indenture entered into between the Company and Odyssey Trust …

Fate Therapeutics Announces Phase 1 Data Presentation of FT819 Off-the-Shelf CAR T-cell Product Candidate for SLE at EULAR 2025 Congress
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular …

Kneat Announces Results of Voting at Annual General Meeting
LIMERICK, Ireland, May 28, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTC: KSIOF) ("Kneat" or the "Company") a leader in digitizing and automating validation processes, announced results from its Annual General Meeting of Shareholders (the "2025 …

Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution
• KHINDIVI is the first and only FDA-approved hydrocortisone oral solution • Commercial launch expected the week of June 2nd • Eton expects combined peak sales of KHINDIVI and ALKINDI SPRINKLE® (hydrocortisone) oral granules to exceed $50 million DEER PARK …

Astrotech Corporation Appoints Jennifer Cañas as Chief Financial Officer
AUSTIN, Texas, May 28, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or (“Astrotech”), today announced that it has appointed Jennifer Cañas as Chief Financial Officer (“CFO”) of the Company. Ms. Cañas’ appointment is …

IMUNON Closes Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules
$3.25 million upfront with up to an additional $6.5 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants LAWRENCEVILLE, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company …

Quorum Announces Q1 2025 Results and Board Changes
CALGARY, Alberta, May 28, 2025 (GLOBE NEWSWIRE) -- Quorum Information Technologies Inc. (TSX-V: QIS) (“Quorum”), a North American SaaS Software and Services company providing essential enterprise solutions that automotive dealerships and Original Equipment …

JetStor Unveils Infinite: The World’s First Data Platform as a Service (DPaaS) Revolutionizing Enterprise Storage
PITTSBURGH, May 28, 2025 (GLOBE NEWSWIRE) -- JetStor, a pioneer in high-performance data storage, today launched JetStor Infinite, the industry’s first Data Platform as a Service (DPaaS). By unifying direct-attached storage (DAS), network-attached storage …

Healios K.K. to Present at the 2025 Jefferies Global Healthcare Conference
NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- HEALIOS K.K. (“Healios”) is pleased to announce that Richard Kincaid, Chief Financial Officer, will present at the 2025 Jefferies Global Healthcare Conference in New York City as follows: Date …

NVIDIA Announces Financial Results for First Quarter Fiscal 2026
Revenue of $44.1 billion, up 12% from Q4 and up 69% from a year ago Data Center revenue of $39.1 billion, up 10% from Q4 and up 73% from a year ago SANTA CLARA, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- NVIDIA (NASDAQ: NVDA) today reported revenue for the …

HP Inc. Reports Fiscal 2025 Second Quarter Results
PALO ALTO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- HP (NYSE: HPQ) Second quarter GAAP diluted net earnings per share ("EPS") of $0.42, down 31% from the prior year period Second quarter non-GAAP diluted net EPS of $0.71, down 13% from the prior year …

Supernus Announces Paragraph IV ANDA Filings for Qelbree®
ROCKVILLE, Md., May 28, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that …

Supernus to Participate in the 2025 Jefferies Global Healthcare Conference
ROCKVILLE, Md., May 28, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that …

ORIC® Pharmaceuticals Announces $125 Million Private Placement Financing
Financing led by SR One and includes participation from new and existing investors, including Point72, Viking Global Investors, Venrock Healthcare Capital Partners, New Enterprise Associates (NEA), Nextech, Vivo Capital, and NEXTBio Capital Pro forma cash …

nCino Reports First Quarter Fiscal Year 2026 Financial Results
• Total Revenues of $144.1M, up 13% year-over-year • Subscription Revenues of $125.6M, up 14% year-over-year WILMINGTON, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking …

Outdoor Holding Company Announces Settlement and Leadership Transition
Board Appoints Steve Urvan, Founder of GunBroker.com and Largest Shareholder, as Chairman and CEO Announces Regained Compliance with Nasdaq Listing Rule Regarding Timely Periodic Reporting SCOTTSDALE, Ariz., May 28, 2025 (GLOBE NEWSWIRE) -- Outdoor Holding …

Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the company will be presenting at the Goldman Sachs …